TORONTO, ON--(Marketwired - Oct 23, 2014) - Easton Pharmaceuticals Inc. (OTC: EAPH) announces it has launched a Vaporizer initiative and responds to shareholder questions.

Easton has retained the services of Toronto based Digitalshock Media for Development and launch of its vaporizer initiatives and associated SEO and web marketing campaign for all product lines. Digital Shock's client list has included Disney, Coca Cola, EA Games, Activision, SEGA and Gameloft.

Digital Shock CEO Mr. Thanhda Tie stated, "We are pleased to have been retained by Easton Pharmaceuticals and to provide our services in the Vaporizer industry which Digitalshock Media has much knowledge and expertise in as a full solution provider. DigitalShock Media plans to also provide SEO and other marketing and development services." Mr. Tie further commented, "We look forward to a progressive relationship and one where our services will greatly benefit Easton on multiple fronts including brand awareness."

Easton Pharmaceuticals has acquired a 100% ownership in websites as well as revenue generating and its internet and wholesale business. Easton plans to carry not only our own exclusive branded products, OTC products, celebrity endorsed product lines but market and distribute all competitor products as well. Approximate timeline for website adaption will be 2 weeks.

Carla Pepe, CEO of Easton Pharmaceuticals commented, "Easton will initially lead with vaporizers and expand into Glassware and E liquids. Easton has already secured purchase agreements for glassware, E liquids and we are open to carrying all competitor vaporizer products to go along with our own brand. We are very much committed and diligently striving towards attaining revenues and profits." Is a currently operational and revenue generating website in the vapor and accessories sectors. Over the next few days it will be transformed to reflect product lines as well as serve as a platform to market related products. is to be a new branded ecommerce site that will help address the vision set forth by Easton management. An agreement has been put in place whereby Digital Shock Media will manage these websites as well as order fulfillment on behalf of Easton.

On October 7th 2014 Easton issued a shareholder letter in which many points were discussed with its shareholders. We are pleased to see the outpouring of information and related questions that have been directed to the company's email address which we would like to address on the most asked.

Shareholders have made query's about pertinent news events that could have a material effect on the company's stock price:

US reclassification of Marijuana from Schedule 1 would allow for greater access to growth and prospects for Easton in the Medical Marijuana sector. Should the State Of Florida approve the amendment on its November 4th ballot it will assist to speed the acceptance of Marijuana as a medicine that helps treat people who suffer from many conditions and ailments including ALS and Cancer. Other states that have a ballot on the 4th on November include Alaska, Oregon, Main and Washington D.C. Easton is in current discussions with US marijuana producers in California, Colorado and Washington to make investments and is very encouraged by current US policies that support such legalization actions.

Important news in the Marijuana Legal front that may have an impact on Easton's MMJ initiatives:

Testimony regarding the constitutionality of the federal statute designating marijuana as a Schedule I Controlled Substance will be taken on Monday, October 27 in the United States District Court for the Eastern District of California in the case of United States v. Pickard, et. al., No. 2:11-CR-0449-KJM.

The Florida Right to Medical Marijuana Initiative, Amendment 2 is on the November 4, 2014 ballot in the state of Florida as an initiated constitutional amendment. The measure, upon voter approval, would legalize medical marijuana.,_Amendment_2_(2014)

John Morgan, an Orlando trial attorney who has spent nearly $4 million of his own money getting the proposal onto the Florida November ballot and pushing its passage, has become a flashpoint in the debate over the measure. Democratic candidate for governor Charlie Crist promoting the bill.

Shareholders have inquired about Eastons current relationship with Modern Mobility Aids, Inc. and it's current option to purchase an ownership interest in an MMPR facility located just outside of Toronto, Ontario, currently awaiting an MMPR growers license. The company subsequently disclosed receiving a financing commitment from a private investor to fully fund Easton's 49% ownership option once the MMPR license was granted. However, many have asked for clarification on the economics of the transaction as it is believed that medical marijuana business evaluations and the current MMJ environment in Canada has negatively changed since the spring of 2014:

Carla Pepe, CEO Of Easton Pharmaceuticals commented, "Easton has invested much time and effort into the original negotiation and the securing of this purchase option to obtain 49% in an MMPR facility, as well as the financing commitment that accompanied it. Still we cannot ignore the clear economics of the agreement and of the current environment, which we believe have changed since it was completed earlier this year. As a result the company is making efforts to renegotiate the original option agreement towards more favorable terms."

What is a Vaporizer?

A vaporizer functions by heating the cannabinoids or E-Liquids to their boiling temperature. Instead of the buds burning and producing copious amounts of smoke, a vaporizer dehydrates the buds and causes them to release their yield without ever catching fire and subsequently mixing with chemicals in the air as the oxygen burns.

As a result, the nasty byproducts of smoking are eliminated. There's no need for an ashtray as the buds can simply be disposed of once they've been exhausted of their beneficial compounds. Clogged pipes of all kinds become a thing of the past, resin buildup is eliminated and the teeth no longer become stained by all that hot smoke.

In addition, the scent associated with burning is greatly reduced. While it isn't entirely eliminated, it does not linger as long or as noticeably as smoke; the smell also does not carry as far as a result. This is a fantastic benefit for both remaining incognito and preventing the smell from accumulating in furniture, clothing, curtains and hair. It is also much more neighbor-friendly, as the chances of them being exposed to secondhand smoke or an unwanted smell is reduced by the factors listed above.

About Easton Pharmaceuticals

Easton Pharmaceuticals is a specialty pharmaceutical company involved in various pharmaceutical sectors and others industries such as medical marijuana. The Company owns, designs, develops, and markets topically-delivered drugs and therapeutic / cosmetic healthcare products, focused on cancer and other health issues geared towards male and female sexual dysfunction, wound healing, pain, motion sickness, scar and stretch marks, cellulite, varicose veins and other conditions. The company has ventured into the potentially lucrative medical marijuana industry through an investment into AMFIL Technologies and their groZONE anti-bacterial system and the exclusive option to purchase up to 50% in a medical marijuana grow-op business / facility which has received a letter to build from Health Canada. The company's gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of Cannabidiol extracts.

For More Information Visit:

Safe Harbor

This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when used in the preceding of discussion, the words "hope", "anticipate," "pleased," "plan," "confident that," "believe," "expect," "possible" or "intent to" and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Any investment made into Easton Pharmaceuticals would be classified as speculative. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company's financial reports and filings.

Contact Information:


Carla Pepe
Easton Pharmaceuticals Inc.
Tel: +1(416) 619-0291
Tel: +1(347) 284-0192